New injection could rival PRP for shoulder pain relief

NCT ID NCT06160427

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study compares two types of injections for people with shoulder pain caused by rotator cuff tendinopathy. One injection, CTM Boost, is made from donated placental tissue, and the other, PRP, uses a patient's own blood. The goal is to see if CTM Boost works as well as PRP at reducing pain and improving shoulder function after a single injection. The trial involves 92 adults aged 18 to 80.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Connective Tissue Matrix (CTM) Boost, a biologic derived from placental connective tissue, and Platelet Rich Plasma (PRP), made from the patient's own blood
What this could lead to
If CTM Boost proves as effective as PRP, it could offer another treatment option for people with shoulder pain from rotator cuff tendinopathy.
What could go wrong
This is a relatively small, single-center trial comparing two existing treatments, so results may not apply broadly. There is also a chance CTM Boost is less effective than PRP.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ROTATOR CUFF TENDINITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AHN Wexford Health & Wellness Pavilion

    Wexford, Pennsylvania, 15090, United States

  • AHN Wexford Hospital

    Wexford, Pennsylvania, 15090, United States

  • Allegheny Health Network Allegheny General Hospital

    Pittsburgh, Pennsylvania, 15212, United States

  • Allegheny Health Network Federal North Medical Office Building

    Pittsburgh, Pennsylvania, 15212, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.